A Fiorentino1, R Caivano, P Pedicini, V Fusco. 1. Department of Radiation Oncology, IRCCS/CROB, via San Pio 1, 85028, Rionero in Vulture, PZ, Italy. albafiorentino@hotmail.it
Abstract
PURPOSE: To assess the differences between the target delineation using computed tomography (CT) and imaging fusion CT/magnetic resonance imaging (MRI) for the radiotherapy planning of glioblastoma. METHODS: One hundred-twenty gross tumor volume and clinical target volume on CT and MRI (GTVCT/CTVCT, GTVMRI/CTVMRI, respectively) were contoured and evaluated. The treatments planning (total dose 60 Gy) based on CTVCT were analysed in terms of percentage of CTVCT and CTVMRI receiving 95 % of the prescribed dose (V95-CTVCT, V95-CTVMRI). RESULTS: GTVs and CTVs contoured on MRI were significantly larger than those delineated on CT (p = 0.0003, p = 0.0006, respectively). Nighty-two percent of CTVCT was coincident with the CTVMRI and 8 % was normal tissue; 20 % of CTVMRI, considered as tumor volume, was not included on CTVCT. The V95-CTVMRI was significantly lower than the V95-CTVCT (p = 0.0005). CONCLUSIONS: In the delineation of glioblastoma target volume, fusion CT/MRI was preferred. The CT only is insufficient for the CTV dose coverage.
PURPOSE: To assess the differences between the target delineation using computed tomography (CT) and imaging fusion CT/magnetic resonance imaging (MRI) for the radiotherapy planning of glioblastoma. METHODS: One hundred-twenty gross tumor volume and clinical target volume on CT and MRI (GTVCT/CTVCT, GTVMRI/CTVMRI, respectively) were contoured and evaluated. The treatments planning (total dose 60 Gy) based on CTVCT were analysed in terms of percentage of CTVCT and CTVMRI receiving 95 % of the prescribed dose (V95-CTVCT, V95-CTVMRI). RESULTS: GTVs and CTVs contoured on MRI were significantly larger than those delineated on CT (p = 0.0003, p = 0.0006, respectively). Nighty-two percent of CTVCT was coincident with the CTVMRI and 8 % was normal tissue; 20 % of CTVMRI, considered as tumor volume, was not included on CTVCT. The V95-CTVMRI was significantly lower than the V95-CTVCT (p = 0.0005). CONCLUSIONS: In the delineation of glioblastoma target volume, fusion CT/MRI was preferred. The CT only is insufficient for the CTV dose coverage.
Authors: P Farace; M G Giri; G Meliadò; D Amelio; L Widesott; G K Ricciardi; S Dall'Oglio; A Rizzotti; A Sbarbati; A Beltramello; S Maluta; M Amichetti Journal: Br J Radiol Date: 2010-11-02 Impact factor: 3.039
Authors: Eric L Chang; Serap Akyurek; Tedde Avalos; Neal Rebueno; Chris Spicer; John Garcia; Robin Famiglietti; Pamela K Allen; K S Clifford Chao; Anita Mahajan; Shiao Y Woo; Moshe H Maor Journal: Int J Radiat Oncol Biol Phys Date: 2007-02-15 Impact factor: 7.038
Authors: June L Chan; Susan W Lee; Benedick A Fraass; Daniel P Normolle; Harry S Greenberg; Larry R Junck; Stephen S Gebarski; Howard M Sandler Journal: J Clin Oncol Date: 2002-03-15 Impact factor: 44.544
Authors: Mario Balducci; Alba Fiorentino; Pasquale De Bonis; Silvia Chiesa; Stefania Manfrida; Giuseppe Roberto D'Agostino; Giovanna Mantini; Vincenzo Frascino; Gian Carlo Mattiucci; Berardino De Bari; Annunziato Mangiola; Francesco Miccichè; Maria Antonietta Gambacorta; Gabriella Colicchio; Alessio Giuseppe Morganti; Carmelo Anile; Vincenzo Valentini Journal: Med Oncol Date: 2012-06-07 Impact factor: 3.064
Authors: Brigitta G Baumert; Michael Brada; Jacques Bernier; Rolf D Kortmann; Cary Dehing-Oberije; Laurence Collette; J Bernard Davis Journal: Radiother Oncol Date: 2008-04-30 Impact factor: 6.280
Authors: Roger Stupp; Monika E Hegi; Warren P Mason; Martin J van den Bent; Martin J B Taphoorn; Robert C Janzer; Samuel K Ludwin; Anouk Allgeier; Barbara Fisher; Karl Belanger; Peter Hau; Alba A Brandes; Johanna Gijtenbeek; Christine Marosi; Charles J Vecht; Karima Mokhtari; Pieter Wesseling; Salvador Villa; Elizabeth Eisenhauer; Thierry Gorlia; Michael Weller; Denis Lacombe; J Gregory Cairncross; René-Olivier Mirimanoff Journal: Lancet Oncol Date: 2009-03-09 Impact factor: 41.316
Authors: A F Thornton; H M Sandler; R K Ten Haken; D L McShan; B A Fraass; M L La Vigne; B R Yanke Journal: Int J Radiat Oncol Biol Phys Date: 1992 Impact factor: 7.038
Authors: Tilman Bostel; Asja Pfaffenberger; Stefan Delorme; Constantin Dreher; Gernot Echner; Peter Haering; Clemens Lang; Mona Splinter; Frederik Laun; Marco Müller; Oliver Jäkel; Jürgen Debus; Peter E Huber; Florian Sterzing; Nils H Nicolay Journal: Strahlenther Onkol Date: 2018-01-18 Impact factor: 3.621